China Resources Sanjiu Medical & Pharmaceutical (000999.SZ): Currently, the company has no equity cooperation with Thalys Medical Technology Group Corporation.

On December 11, Gelonghui reported that China Resources Sanjiu Medical & Pharmaceutical (000999.SZ) stated on the investor interaction platform that the company currently has no equity cooperation with Thalys Medical Technology Group Corporation.

Gelonghui FinanceDec 11, 2024 02:13 ET

Thalys Medical Technology Group (SHSE:603716) Adds CN¥381m to Market Cap in the Past 7 Days, Though Investors From Five Years Ago Are Still Down 45%

Simply Wall StNov 13, 2024 17:21 ET

Improved Revenues Required Before Thalys Medical Technology Group Corporation (SHSE:603716) Stock's 32% Jump Looks Justified

Simply Wall StNov 13, 2024 17:08 ET

Celi Healthcare: third quarter report 2024

SZSIOct 28, 2024 12:00 ET · Announcements

Third Quarter Report 2024

SZSIOct 28, 2024 12:00 ET · Announcements

Thalys Medical Technology Group Corporation (603716.SH) released its performance for the first three quarters, with a net loss of 56.0251 million yuan.

Thalys Medical Technology Group Corporation (603716.SH) released its third quarter report for 2024, with a revenue of 14...

Zhitong FinanceOct 28, 2024 08:49 ET